Patent · US Active

Pyrazolopyrimidine antibacterial agents

US10155766B2 · kind B2 · utility

0Cited by
4References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2017
Grant dateDec 18, 2018
Priority date
Expiry dateJun 1, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pyrazolopyrimidine compounds for inhibition of isoprenoid biosynthesis have a formula (I) or a pharmaceutically acceptable salt thereof. In formula (I), R1 includes an alkyl group and R2 includes an optionally substituted moiety selected from the group consisting of an optionally substituted benzyl group, an optionally substituted phenethyl group, an optionally substituted ethanol group, an optionally substituted ethyl acetate group, an optionally substituted methyl furan group, an optionally substituted 3-ethyl indole group, and a lower alkyl group. Compositions containing pyrazolopyrimidine compounds and methods for using pyrazolopyrimidine compounds are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.